UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2168 - 2181
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myeloproliferative Disorders - diagnosis | Gene Expression | Age Factors | Myeloproliferative Disorders - therapy | Humans | Male | Polycythemia Vera - genetics | Antineoplastic Agents - therapeutic use | Leukemia, Myeloid, Acute - etiology | Polycythemia Vera - therapy | Thrombocythemia, Essential - genetics | Myeloproliferative Disorders - genetics | Phenotype | Primary Myelofibrosis - genetics | Bone Marrow Transplantation | Sex Factors | Thrombocythemia, Essential - therapy | Female | Myeloproliferative Disorders - complications | Primary Myelofibrosis - therapy | Mutation | Hematopoietic Stem Cells | Care and treatment | Usage | Therapeutics | Diagnosis | Research | Myeloproliferative disorders | Homeopathy | Materia medica and therapeutics | Myelofibrosis | Hematology | Pathogenesis | Leukemia | Polycythemia vera | Patients | Myeloproliferative diseases | Hemopoiesis | Polycythemia | Epigenetics | Thrombocytosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 02/2017, Volume 129, Issue 6, pp. 704 - 714
Life Sciences & Biomedicine | Hematology | Science & Technology | Eosinophilia - therapy | Oncogene Proteins, Fusion - metabolism | Leukemia - pathology | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Humans | Gene Expression Regulation, Neoplastic | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | fms-Like Tyrosine Kinase 3 | Antineoplastic Agents - therapeutic use | Myeloproliferative Disorders - pathology | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Receptor, Platelet-Derived Growth Factor beta - genetics | Myeloproliferative Disorders - genetics | Transplantation, Homologous | Eosinophilia - pathology | Hypereosinophilic Syndrome - diagnosis | Receptor, Platelet-Derived Growth Factor beta - antagonists & inhibitors | Receptor, Platelet-Derived Growth Factor alpha - antagonists & inhibitors | Janus Kinase 2 - metabolism | Eosinophilia - genetics | Hypereosinophilic Syndrome - pathology | Hypereosinophilic Syndrome - therapy | Eosinophilia - diagnosis | Janus Kinase 2 - antagonists & inhibitors | Leukemia - genetics | Receptor, Platelet-Derived Growth Factor beta - metabolism | Myeloproliferative Disorders - diagnosis | Proto-Oncogene Proteins c-abl - genetics | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Myeloproliferative Disorders - therapy | Janus Kinase 2 - genetics | Hematopoietic Stem Cell Transplantation | Leukemia - therapy | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Receptor, Platelet-Derived Growth Factor alpha - genetics | Leukemia - diagnosis | Proto-Oncogene Proteins c-abl - metabolism | Hypereosinophilic Syndrome - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 09/2013, Volume 122, Issue 13, pp. 2176 - 2184
Journal Article
British journal of haematology, ISSN 0007-1048, 08/2016, Volume 174, Issue 3, pp. 382 - 396
epidemiology | myeloproliferative neoplasm | incidence | survival | Life Sciences & Biomedicine | Hematology | Science & Technology | Myelodysplastic-Myeloproliferative Diseases - epidemiology | United States - epidemiology | Age Factors | Humans | Middle Aged | Myeloproliferative Disorders - classification | Infant | Male | Incidence | Myelodysplastic-Myeloproliferative Diseases - mortality | Ethnic Groups | Sex Factors | Survival Analysis | Myeloproliferative Disorders - epidemiology | Female | Aged | Myelodysplastic-Myeloproliferative Diseases - classification | Infant, Newborn | Myeloproliferative Disorders - mortality | Epidemiology | Leukemia | Patient outcomes | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 895 - 895
Journal Article
JAMA oncology, ISSN 2374-2437, 04/2015, Volume 1, Issue 1, pp. 97 - 105
Life Sciences & Biomedicine | Oncology | Science & Technology | Myeloproliferative Disorders - diagnosis | Predictive Value of Tests | Genetic Predisposition to Disease | Myeloproliferative Disorders - enzymology | Myeloproliferative Disorders - therapy | Humans | Janus Kinase 2 - genetics | Treatment Outcome | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Calreticulin - genetics | Myeloproliferative Disorders - genetics | Stem Cell Transplantation | Receptors, Thrombopoietin - genetics | Phenotype | Protein Kinase Inhibitors - therapeutic use | Janus Kinase 2 - metabolism | Biomarkers, Tumor - metabolism | Biomarkers, Tumor - genetics | Mutation | Biomarkers, Tumor - antagonists & inhibitors | Janus Kinase 2 - antagonists & inhibitors | Myeloproliferative Disorders - mortality | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 894 - 896
Journal Article
Cancer Epidemiology Biomarkers & Prevention, ISSN 1055-9965, 07/2009, Volume 18, Issue 7, pp. 2068 - 2073
JAK2V617F mutation | Lymphoproliferative neoplasms | Risk | Polycythemia vera | Myeloproliferative neoplasms | Oncology | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Humans | Middle Aged | Male | Polycythemia Vera - genetics | Thrombocythemia, Essential - genetics | Myeloproliferative Disorders - genetics | Incidence | Polycythemia Vera - epidemiology | Young Adult | Janus Kinase 2 - metabolism | Polymerase Chain Reaction | Aged, 80 and over | Myeloproliferative Disorders - epidemiology | Adult | Female | Registries | Retrospective Studies | Philadelphia Chromosome | Lymphoma - epidemiology | Janus Kinase 2 - genetics | Lymphoma - genetics | Genotype | Thrombocythemia, Essential - epidemiology | Adolescent | Italy - epidemiology | Aged | Mutation | Cohort Studies | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 894 - 895
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2018, Volume 379, Issue 15, pp. 1416 - 1430